These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37480596)

  • 1. Cellular mechanisms in the pathogenesis of interstitial lung diseases.
    Singh P; Ali SN; Zaheer S; Singh M
    Pathol Res Pract; 2023 Aug; 248():154691. PubMed ID: 37480596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microscopic organizing pneumonia and cellular non-specific interstitial pneumonia are widespread in macroscopically normal-appearing lung tissue in idiopathic pulmonary fibrosis.
    Todd NW; Galvin JR; Sachdeva A; Luzina IG; Atamas SP; Burke AP
    J Heart Lung Transplant; 2016 Nov; 35(11):1367-1370. PubMed ID: 27590591
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players.
    Samarelli AV; Tonelli R; Marchioni A; Bruzzi G; Gozzi F; Andrisani D; Castaniere I; Manicardi L; Moretti A; Tabbì L; Cerri S; Beghè B; Dominici M; Clini E
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases.
    Lai Y; Wei X; Ye T; Hang L; Mou L; Su J
    Front Immunol; 2021; 12():747335. PubMed ID: 34804029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological Insight into 5-HT
    Löfdahl A; Tornling G; Wigén J; Larsson-Callerfelt AK; Wenglén C; Westergren-Thorsson G
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging and interstitial lung diseases: unraveling an old forgotten player in the pathogenesis of lung fibrosis.
    Selman M; Rojas M; Mora AL; Pardo A
    Semin Respir Crit Care Med; 2010 Oct; 31(5):607-17. PubMed ID: 20941661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Senescence in Lung Fibrosis.
    Hernandez-Gonzalez F; Faner R; Rojas M; Agustí A; Serrano M; Sellarés J
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers.
    Drakopanagiotakis F; Markart P; Steiropoulos P
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute exacerbations of interstitial lung disease.
    Azadeh N; Moua T; Baqir M; Ryu JH
    Expert Rev Respir Med; 2018 Apr; 12(4):309-313. PubMed ID: 29486130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bleomycin Model of Pulmonary Fibrosis.
    Liu T; De Los Santos FG; Phan SH
    Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease.
    Valenzi E; Tabib T; Papazoglou A; Sembrat J; Trejo Bittar HE; Rojas M; Lafyatis R
    Front Immunol; 2021; 12():595811. PubMed ID: 33859634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D In Vitro Models: Novel Insights into Idiopathic Pulmonary Fibrosis Pathophysiology and Drug Screening.
    Vazquez-Armendariz AI; Barroso MM; El Agha E; Herold S
    Cells; 2022 May; 11(9):. PubMed ID: 35563831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic pulmonary fibrosis-epidemiology, causes, and clinical course].
    Schäfer SC; Funke-Chambour M; Berezowska S
    Pathologe; 2020 Feb; 41(1):46-51. PubMed ID: 31993696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK506-Binding Protein 13 Expression Is Upregulated in Interstitial Lung Disease and Correlated with Clinical Severity. A Potentially Protective Role.
    Tat V; Ayaub EA; Ayoub A; Vierhout M; Naiel S; Padwal MK; Abed S; Mekhael O; Tandon K; Revill SD; Yousof T; Bellaye PS; Kolb PS; Dvorkin-Gheva A; Naqvi A; Cutz JC; Hambly N; Kato J; Vaughan M; Moss J; Kolb MRJ; Ask K
    Am J Respir Cell Mol Biol; 2021 Feb; 64(2):235-246. PubMed ID: 33253593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease.
    Barratt SL; Flower VA; Pauling JD; Millar AB
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clubbing in patients with fibrotic interstitial lung diseases.
    van Manen MJG; Vermeer LC; Moor CC; Vrijenhoeff R; Grutters JC; Veltkamp M; Wijsenbeek MS
    Respir Med; 2017 Nov; 132():226-231. PubMed ID: 29229102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes.
    Iyoda A; Azuma Y; Sakamoto S; Homma S; Sano A
    Surg Today; 2022 May; 52(5):736-744. PubMed ID: 34347162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies.
    Diesler R; Cottin V
    Expert Rev Respir Med; 2022 May; 16(5):541-553. PubMed ID: 35695895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared Mechanistic and Phenotypic Traits Suggest Overlapping Disease Mechanisms.
    Paulin F; Doyle TJ; Fletcher EA; Ascherman DP; Rosas IO
    Rev Invest Clin; 2015; 67(5):280-6. PubMed ID: 26696331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse lung diseases in cigarette smokers.
    Vassallo R
    Semin Respir Crit Care Med; 2012 Oct; 33(5):533-42. PubMed ID: 23001806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.